Compare DuPont de Nemours Inc (DD) vs Morgan Stanley (MS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DuPont de Nemours Inc vs Morgan Stanley — how do they compare? DuPont de Nemours Inc trades at $130.15 (market cap $17.89B), while Morgan Stanley trades at $190.41 (market cap $294.39B). The key difference: Morgan Stanley is far larger — about 16.5× DuPont de Nemours Inc's market cap, and Morgan Stanley pays the higher dividend (2.45%). Which is the better fit depends on your goals — on Pluang, investors hold DuPont de Nemours Inc for 89 Days and Morgan Stanley for 92 Days on average.
| DD | MS | |
|---|---|---|
Market Cap | $17.89B | $294.39B |
Volume | 816,409 | 5,836,423 |
Sector | Basic Materials | Financials |
52-Week High | $154.59 | $228.42 |
52-Week Low | $92.49 | $151.86 |
Typical Hold Time | 89 Days | 92 Days |
Enterprise Value | $19.28B | $660.04B |
Dividend Yield | 1.81% | 2.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $130.00, down 0.82% on the day, with a neutral technical signal and mixed financial trends. Recent earnings beats in Q4 2025, Q1 2026, and Q2 2026 contrast with a net loss of $779 million in 2025, though 2026 forecasts show a return to profitability. The company faces headwinds from PFAS litigation settlements and volatile cash flows, but innovation in areas like Tyvek and water technology supports long-term growth prospects.
The outlook for DD is cautiously optimistic, driven by secular growth in healthcare and water technologies, but weighed down by legal liabilities and margin pressures. Analyst consensus is bullish with a 58.54% buy rating, though the $95.00 price target suggests downside risk from current levels. Key risks include ongoing litigation costs and economic sensitivity in construction markets.
Morgan Stanley (MS) trades at $189.71, down 0.66% with bearish technical signals despite strong fundamentals. The company has delivered three consecutive earnings beats with Q2 2026 EPS of $3.46 beating expectations by $0.57. Revenue growth accelerated to $66.0 billion in 2025 with net income margin expanding to 27.59%. Analyst consensus remains bullish with 55.77% buy ratings and a $229.25 price target representing 21% upside potential.
The investment case balances strong profitability and growth opportunities in wealth management and AI financing against concerning cash flow trends and technical weakness. While valuation appears reasonable at 15.14 P/E, investors face risks from volatile operating cash flows and rising debt levels. The stock offers attractive upside to analyst targets but requires monitoring of capital markets recovery timing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DuPont de Nemours Inc
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →
